Aggregates, curates and creates bottom-line content weeding of sector news to provide a customized, vetted selection of relevant and high-impact synthesis.
Since 2001, as an online news and digital media publisher; our mission is to provide readers with exclusive, in-depth coverage of cell therapy companies, technology, and investing funds. Our vision is to provide time sensitive intelligence and metrics to define the ever changing economics of regenerative medicine.
We are focused on providing value-added intelligence and insightful investment conclusions on emerging companies demonstrating real progress toward their vision while meeting quarterly expectation. Our mission is unchanged from the day we were founded: that is to provide objective, comprehensive and timely research. It is about timely, credible, and insightful analysis.
We constantly leverage our research capabilities employing various methodologies, including fundamental, technical and qualitative narrative approaches. We strive to improve our company comparable analysis, valuation and quantitative models by providing timely and accurate assumptions of the drivers to derive a company’s financial performance.
Now in our tenth (10) year, we bring extensive experience in finance, capital markets, investment analysis, corporate operations and due diligence.